Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
To evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing the percentage
 of subjects who reach target blood pressure (BP) and LDL-C targets as defined by their
 governing guidelines.
Inclusion Criteria:

 -  Treated or untreated subjects with concurrent hypertension and dyslipidemia with BP
 and LDL-C not at target according to governing guidelines

 Exclusion Criteria:

 -  High liver enzymes